Neal Walker - 04 Dec 2024 Form 4 Insider Report for Aclaris Therapeutics, Inc. (ACRS)

Signature
/s/ Matthew Rothman, Attorney-in-Fact
Issuer symbol
ACRS
Transactions as of
04 Dec 2024
Net transactions value
-$76,333
Form type
4
Filing time
06 Dec 2024, 16:15:10 UTC
Previous filing
03 Dec 2024
Next filing
03 Jan 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACRS Common Stock Options Exercise $180,637 +118,840 +8.6% $1.52 1,501,973 04 Dec 2024 Direct
transaction ACRS Common Stock Tax liability $256,970 -68,343 -4.6% $3.76 1,433,630 04 Dec 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACRS Employee Stock Option (right to buy) Options Exercise $0 -118,840 -100% $0.000000 0 04 Dec 2024 Common Stock 118,840 $1.52 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction reported represents the withholding of shares by the Issuer to satisfy the exercise price and the Reporting Person's tax withholding obligations in connection with the option exercise described in this Form 4.
F2 Fully vested and exercisable.